Gentler radiation joins forces with drugs to attack tough colon tumors
NCT ID NCT07279077
Summary
This study is testing a new three-part treatment for people with high-risk colon cancer that hasn't spread. The goal is to shrink the tumor as much as possible before surgery. Patients receive a very low dose of radiation designed to spare lymph nodes, along with standard chemotherapy and an immunotherapy drug. Researchers hope this combination will help the immune system attack the cancer more effectively and lead to better outcomes.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLON CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
The Sixth Affiliated Hospital of Sun Yat-sen University
RECRUITINGGuangzhou, Guangdong, 510655, China
Contact Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.